Our group has a strong track record of attracting funding from prestigious national and international funding bodies including the National Institute for Health and Care Research, Medical Research Council, Diabetes UK, Cancer Research UK, European Commission and AstraZeneca UK. Some examples of our current and past awarded grants can be found below:
Research England; Yates T, Edwardson C. Expansion of Leicester Lifestyle and Health Research Group. £14,000,000; 2024-2029.
Abbott; Yates T (PI). The impact of providing continuous glucose monitoring devices to people with type 2 diabetes. £310,593; 2023-2025.
NIHR Work & Health Development Award. Maidment D, Barrow H, Munir F, Nielsen K, Shemtob L, Burton K, Baryts S, Marwaha S, Yarker J, Edwardson C, Ballard J. Hemming S. Self-management support to enhance work-health balance in people with long-term health conditions and disabilities. £118,038.00. 2023-2024.
NIHR Leicester Biomedical Research Centre; Yates T as Lifestyle Co-PI responsible for £4,320,477; 2022-2027.
NIHR Health Technology Assessment; Goff LM (PI), McGowan B, Robinson C, Harris T, Ussher M, Ashworth M, Dale J, Healey A, Jin H, Bower P, Rivas C, Thorpe J, Hoverd E, Tomlinson S, Kelly T. HEAL-D (Healthy Eating & Active Lifestyles for Diabetes): a multicentre, pragmatic randomised controlled trial comparing effectiveness and cost-effectiveness of culturally tailored versus standard diabetes self-management programmes in Black-African and Black-Caribbean adults with type 2 diabetes. £2,329,781.00. 2023-2026.
Reinsurance Group of America collaborative project. Yates T (PI). Understanding the Role of Lifestyle Behaviours as Predictors of All-Cause Mortality and Major Morbidity Outcomes in the UK Biobank. £235,219; 2022-2023.
Cancer Research UK; Coyle V, Russell A, Adams R, Wilson R, Storey D, Yates T (as lead physical activity researcher for UK sites), Booth C, Courneya K, Donnelly M, McAuley D, Thomas A. CHALLENGE UK (A UK arm of the Colon Health And LifeLong Exercise chaNGE trial). £560,971; 2015-2023.
Astra Zeneca investigator-initiated grant: Davies M, Yates T (physical activity lead), McCann G, Khunti K, Sargeant J, Webb D, King J, Redman E, Gulsin G, Smith A, Watson E. Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: a randomised controlled trial. £517,590; 2020-2024.
Medical Research Council; Yates T (UK PI), Dasgupta K, Rahme E, Da Costa D, Chevalier S, Yeung Laiwah R, Boulé N, Thompson R, Fortier I, Davies M, McCann G, Khunti K, Gregg E, Friedrich M, Henson J, Hadjiconstantinou M, Baldry E. REmission of diabetes and improved diastolic function by combining Structured Exercise with meal replacemenT and food reintroduction (RESET). £330,000 (UK funding).
NIHR Programme Grant; Daly A (PI), Biddle S, Edwardson CL, Esliger D, Frew E, Greenfield S, Ives N, Jolly K, Mutrie N, Parretti H, Sherar L, Thursfield C, Yates, T. ‘Snacktivity’ to promote physical activity and reduce future risk of disease in the population. £2,386,941.
Diabetes UK. Bailey D (PI), Chater A, Dong F, Edwardson CL, Hewson D, Pang, D, Pappas Y, Biddle S. A tailored intervention to reduce sitting behaviour in people with Type 2 Diabetes: A randomised controlled feasibility study; £137,510.
UKRI-DHSC COVID-19 Rapid Response Rolling Call; Yates T (PI), Khunti K, Zaccardi F, Razieh C, Davies M. Ethnicity and COVID-19: investigating the determinants of excess risk in UK Biobank; £125,992.
NIHR Public Health Research; Edwardson CL (PI), Yates T, Davies M, Clemes S, Munir F, Granat M, Clarke-Cornwell A, Richardson G, Gray L. A three arm cluster randomised controlled trial to test the effectiveness and cost-effectiveness of the SMArT Work & Life intervention for reducing daily sitting time in office workers. £905,133.90; 2018-2021.
NIHR Public Health Research; Clemes S (PI), Yates T, Edwardson CL, Hamer M, Munir F, King J. A cluster randomised controlled trial to investigate the effectiveness and cost-effectiveness of a Structured Health Intervention For Truckers (The SHIFT Programme). £735,571.
Boehringer Ingelheim; Davies M (PI), Khunti K, Chatterjee S, Stensel D, King J, Yates T, Edwardson CL, Gray L, Bodicoat D. SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation - The SEESAW Study; €497,002.
East Midlands CLAHRC; Khunti K (PI), Yates T, Davies M, Batt M, Edwardson CL, Carey M. Promoting lifestyle change and self-management through structured education in people with multi-morbidity: A randomised controlled trial; £248,858.
NIHR Public Health Research; Clemes S (PI), Barber S, Edwardson CL, Tolfrey K, Cale L, McEachan R, Bandelow s, Fray M, Richardson G. Stand Out in Class: Restructuring the classroom environment to reduce sedentary behaviour - a pilot cluster randomised controlled trial; £418,112.80.
East Midlands CLAHRC. Sherar L (PI), Edwardson CL, Harrington D, Clemes S, Cale L, Khunti K, Biddle S, Bodicoat D, Salmon J. ‘Move to Teach, Move to Learn’ - A collaborative school-based programme to decrease sedentary time in primary school students. £253,468.
NIHR Public Health Research; Davies M (PI), Edwardson CL, Yates T, Harrington D, Gorely T, Sherar L, Bodicoat D. A cluster randomised controlled trial to investigate the effectiveness and cost-effectiveness of the ‘Girls Active’ intervention; £599,444.
European Commission, Directorate-General for Health and Consumers, Unit C.1 Programme Management and Diseases; Davies M (PI), Khunti K, Edwardson CL, Yates T, Gray L, Ribeiro, R, Raposo J, Silva H, Ayala M, Pfäffle R, Blüher S, Schwarz P, de Manuel Keenoy E, Karagiozoglou-Lampoudi T, Gerasimidi-Vazeou A. Call for Tender: No SANCO/2013/C1/004 concerning a pilot project for developing and implementing successful prevention strategies for type 2 diabetes; €999,075.
Department of Health; Biddle SJH, Yates, T, Edwardson CL, Esliger D, Davies M, Gray L, Munir F (PI). SMArT Work: Stand More AT Work; £598,885.
Medical Research Council; Yates T (PI), Edwardson CL, Davies M, Khunti K, Biddle SJH, Esliger D, Gill J, Sattar N, Sinclair A. Sedentary behaviour in older adults: Investigating a new therapeutic paradigm; £1,055,898.
NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit. 2012-2017.